摘要
透皮给药领域因吸收、渗透限制,其上市产品与口服、注射用药市场占有率比较几乎是空白,因此本文总结美国、日本、欧盟以及我国透皮给药上市产品和主要企业,以及各国法规要求,为此类产品开发提供借鉴。
Due to the limitation of absorption and penetration in the field of transdermal drug delivery(TDDS),the market share of its marketed products is almost blank when compared with oral and injectable drugs.Therefore,this article summarizes the products and major companies of transdermal drug delivery in the United States,Japan,the European Union and China,and regulatory requirements in various countries to provide reference for the development of such products.
作者
王秀杰
WANG Xiu-jie(Livzon Pharmaceutical Group Co.,Ltd.,Zhuhai 519090,China)
出处
《海峡药学》
2021年第6期210-212,共3页
Strait Pharmaceutical Journal
关键词
透皮给药
上市产品
主要企业
TDDS类产品法规
Transdermal drug delivery
Listed products
Major companies
TDDS product regulations